Disseminated intravascular coagulation

Last updated: July 19, 2023

Disseminated intravascular coagulation

Heme & Onc

Heme & Onc

Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Blood histology
Erythropoietin
Iron deficiency anemia
Anemia of chronic disease
Sideroblastic anemia
Megaloblastic anemia
Aplastic anemia
Paroxysmal nocturnal hemoglobinuria
Autoimmune hemolytic anemia
Fanconi anemia
Hemolytic disease of the newborn
Hereditary spherocytosis
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate kinase deficiency
Sickle cell disease (NORD)
Beta-thalassemia
Alpha-thalassemia
Lead poisoning
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Mastocytosis (NORD)
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Leukemoid reaction
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Ehrlichia and Anaplasma
Escherichia coli
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Plasmodium species (Malaria)
HIV (AIDS)
HIV and AIDS: Pathology review
Measles virus
Viral hepatitis: Pathology review
Viral hepatitis
Hepatitis C virus
Hepatitis medications
Dengue virus
Yellow fever virus
Cytomegalovirus
Epstein-Barr virus (Infectious mononucleosis)
Bleeding disorders: Clinical
Clostridium perfringens
Staphylococcus epidermidis
Staphylococcus aureus
Streptococcus pneumoniae
Streptococcus pyogenes (Group A Strep)
Enterococcus
Salmonella (non-typhoidal)
Salmonella typhi (typhoid fever)
Pseudomonas aeruginosa
Serratia marcescens
Nocardia
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Neisseria meningitidis
Brucella
Haemophilus influenzae
Mycobacterium avium complex (NORD)
Mycobacterium tuberculosis (Tuberculosis)
Mycoplasma pneumoniae
Borrelia species (Relapsing fever)
Borrelia burgdorferi (Lyme disease)
Varicella zoster virus
Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Adenovirus
Parvovirus B19
Human papillomavirus
JC virus (Progressive multifocal leukoencephalopathy)
Human T-lymphotropic virus
Candida
Pneumocystis jirovecii (Pneumocystis pneumonia)
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Aspergillus fumigatus
Mucormycosis
Cryptococcus neoformans
Babesia
Cryptosporidium
Toxoplasma gondii (Toxoplasmosis)
Leishmania
Strongyloides stercoralis
Diphyllobothrium latum
Ancylostoma duodenale and Necator americanus

Transcript

Watch video only

Content Reviewers

Disseminated intravascular coagulation, or DIC, describes a situation in which the process of hemostasis, which is when after blood vessel wall injury, liquid blood rapidly becomes a gel, called coagulation or clotting, starts to run out of control.

When this happens, lots and lots of blood clots start to form in blood vessels serving various organs, leading to organ ischemia.

DIC, though, is also called a consumption coagulopathy, because all this clotting consumes platelets and clotting factors.

Without enough platelets circulating in the blood, other parts of the body begin to bleed with even the slightest damage to the blood vessel walls. So paradoxically, patients have too much and too little clotting.

Normally, after a cut and damage to the endothelium, or inner lining of blood vessel walls, there’s an immediate vasoconstriction or narrowing of the blood vessel which limits the amount of blood flow.

After that, some platelets adhere to the damaged vessel wall, and become activated and then recruit additional platelets to form a plug.

The formation of the platelet plug is called primary hemostasis.

After that, the coagulation cascade is activated. First off in the blood there’s a set of clotting factors, most of which are proteins synthesized by the liver, and usually these are inactive and just floating around in the blood.

The coagulation cascade starts when one of these proteins gets proteolytically cleaved.

This active protein then proteolytically cleaves and activates the next clotting factor, and so on.

This cascade has a huge degree of amplification and takes only a few minutes from injury to clot formation.

The final step is activation of the protein fibrinogen to fibrin, which deposits and polymerizes to form a mesh around the platelets.

So these steps leading up to fibrin reinforcement of the platelet plug make up the process called secondary hemostasis and results in a hard clot at the site of the injury.

Now, as soon as the clot is formed, the body is also initiating pathways to break down the clot so that it doesn’t get bigger than it needs to be and dissolves when it’s not needed anymore—a process called fibrinolysis.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "How I treat disseminated intravascular coagulation" Blood (2018)
  5. "Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation" Journal of Thrombosis and Haemostasis (2019)
  6. "Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies" Clinical and Applied Thrombosis/Hemostasis (2018)